Cytokinetics (CYTK) net assets (shareholders' equity)

Net assets · fiscal 2025
-$659.63M

Cytokinetics (CYTK) had net assets of -$659.63M at the end of fiscal 2025 (December 31, 2025). In fiscal 2024 the figure was -$135.37M. Figures as of 19 Nov 2026, 11:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
-$659.63M
Highest on record
$243.86Mfiscal 2021
Lowest on record
-$659.63Mfiscal 2025
Fiscal years on record
271999–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Cytokinetics net assets (shareholders' equity), in more detail

Across the 27 fiscal years on record (1999–2025), the highest was $243.86M in fiscal 2021 and the lowest -$659.63M in fiscal 2025.

History · 27 fiscal years

Net assets by fiscal year

Cytokinetics net assets (shareholders' equity), year by year

Cytokinetics (CYTK) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025-$659.63M—
2024-$135.37M—
2023-$386.32M—
2022-$107.90M 144.2% down
2021$243.86M 115.1% up
2020$113.38M—
2019-$10.94M 142.2% down
2018$25.93M 76.4% down
2017$109.84M 16.4% up
2016$94.36M 37.6% up
2015$68.59M 25.5% down
2014$92.06M 69.1% up
2013$54.44M 22.3% down
2012$70.09M 45.5% up
2011$48.18M 31.7% down
2010$70.52M 30.5% down
2009$101.43M 103.8% up
2008$49.77M 50.2% down
2007$99.92M 6.0% down
2006$106.31M 44.5% up
2005$73.56M 31.6% down
2004$107.56M—
2003-$92.03M—
2002-$60.59M—
2001-$37.35M—
2000-$21.82M—
1999-$9.12M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Cytokinetics and comparable companies
CompanyNet assetsFiscal year
Alkermes ALKS$1.82B2025
PACS Group PACS$946.77M2025
Kiniksa Pharmaceuticals International KNSA$567.61M2025
ImmunityBio IBRX-$500.47M2025
Cytokinetics CYTK-$659.63M2025
ABIVAX ABVX€455.21M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CYTK

Cytokinetics, figure by figure

Cytokinetics (CYTK) overview: price, valuation and scorecardAll health care companies by market value

Cytokinetics net assets (shareholders' equity): questions and answers

What are Cytokinetics's net assets?

Cytokinetics (CYTK) had net assets of -$659.63M at the end of fiscal 2025 (December 31, 2025). In fiscal 2024 the figure was -$135.37M.

What are the highest and lowest net assets figures on record for Cytokinetics?

Across the 27 fiscal years on record (1999–2025), the highest was $243.86M in fiscal 2021 and the lowest -$659.63M in fiscal 2025.

How is Cytokinetics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Cytokinetics it is on record here for 27 fiscal years, 1999 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cytokinetics (CYTK) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/CYTK/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.